腎性貧血治療薬としてのSGLT2阻害薬の可能性

• Project/Area Number: 21K16167
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 53040:Nephrology-related
• Research Institution: Nagoya City University
• Principal Investigator: 小野 水面 名古屋市立大学, 医学(系)研究科(研究院), 助教 (50831137)
• Project Period (FY): 2021-04-01 – 2024-03-31
• Project Status: Adopted (Fiscal Year 2021)
• Budget Amount: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000); Fiscal Year 2023: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000); Fiscal Year 2022: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000); Fiscal Year 2021: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)